Europace 2021; 23:1612–76.
In the originally published version of this manuscript, “Boehringer Ingelheim” was referenced in the funding paragraph. This has been removed.
. 2021 Jun 28;23(10):1676. doi: 10.1093/europace/euab157
Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel
, Ronan Collins
, Matthias Antz
, Pieter Cornu
, Lien Desteghe
, Karl Georg Haeusler
, Jonas Oldgren
, Holger Reinecke
, Vanessa Roldan-Schilling
, Nigel Rowell
, Peter Sinnaeve
, Thomas Vanassche
, Tatjana Potpara
, A John Camm
, Hein Heidbüchel
Jan Steffel
Find articles by Jan Steffel
Ronan Collins
Find articles by Ronan Collins
Matthias Antz
Find articles by Matthias Antz
Pieter Cornu
Find articles by Pieter Cornu
Lien Desteghe
Find articles by Lien Desteghe
Karl Georg Haeusler
Find articles by Karl Georg Haeusler
Jonas Oldgren
Find articles by Jonas Oldgren
Holger Reinecke
Find articles by Holger Reinecke
Vanessa Roldan-Schilling
Find articles by Vanessa Roldan-Schilling
Nigel Rowell
Find articles by Nigel Rowell
Peter Sinnaeve
Find articles by Peter Sinnaeve
Thomas Vanassche
Find articles by Thomas Vanassche
Tatjana Potpara
Find articles by Tatjana Potpara
A John Camm
Find articles by A John Camm
Hein Heidbüchel
Find articles by Hein Heidbüchel
Collection date 2021 Oct.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
PMCID: PMC12098927 PMID: 34179979
This corrects the article "2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation" on page 1612.